Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 156,409 $ 68,615
Accounts receivable 12,215 35,378
Grant receivable 4,991 130,152
Prepaid expenses 72,172 82,765
Total current assets 245,787 316,910
Property and equipment, net 57,363 76,572
Right to use assets 177,454 270,406
Other assets:    
Patents, net 9,322 10,206
Software development costs 0 47,980
Deposits, long term 44,520 44,520
Total other assets 53,842 102,706
Total assets 534,446 766,594
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,491,414 and $1,077,088, respectively 4,443,567 3,907,954
Deferred revenue, short term 7,092 33,256
Lease liability, short term 146,187 134,343
Notes payable, net of debt discount of $113,242 and $23,878, respectively 408,238 297,602
Notes payable, related parties, net of debt discount of $106,801 and $49,473, respectively 941,581 990,637
Total current liabilities 5,946,665 5,363,792
Long term liabilities:    
Economic Injury Disaster loan, long term 72,817 73,850
Royalty obligation, net of discount of $5,021,128 and $5,376,790, related parties 3,700,972 3,345,310
Lease liability, long term 70,350 181,328
Deferred revenue, long term 4,045 4,045
Total liabilities 9,794,849 8,968,325
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 8,591,797 and 7,718,636 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 8,592 7,719
Common stock subscribed 100,000 100,000
Additional paid in capital 67,872,232 66,130,296
Accumulated deficit (77,134,478) (74,336,105)
Total deficit attributable to BioCorRx Inc. (9,132,038) (8,076,474)
Non-controlling interest (128,365) (125,257)
Total deficit (9,260,403) (8,201,731)
Total liabilities and deficit 534,446 766,594
Series A Convertible Preferred Stock [Member]    
Deficit:    
Preferred stock, value 16,000 16,000
Convertible Series B Preferred Stock [Member]    
Deficit:    
Preferred stock, value $ 5,616 $ 5,616